Universal screening versus risk‐based protocols for antibiotic prophylaxis during childbirth to prevent early‐onset group B streptococcal disease: a systematic review and meta‐analysis
GF Hasperhoven,S Al‐Nasiry,V Bekker,E Villamor,BWW Kramer
DOI: https://doi.org/10.1111/1471-0528.16085
2020-02-04
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Early‐onset group B streptococcal (EOGBS) disease (including sepsis, meningitis, and pneumonia) causes significant morbidity and mortality in newborn infants worldwide. Antibiotic prophylaxis can prevent vertical streptococcal transmission, yet no uniform criteria to identify eligible women for prophylaxis exist. Some guidelines recommend universal GBS screening to pregnant women in their third trimester (screening‐based protocol), while others employ risk‐based protocols.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>To compare the effectiveness of screening‐based vs risk‐based protocols in preventing EOGBS disease.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Search Strategy</h3><p>Key words for the database searches included GBS, <i>Streptococcus agalactiae</i>, pregnancy, screening, culture‐based, risk‐based. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Selection Criteria</h3><p>Studies were included if they investigated EOGBS disease incidence in newborn infants and compared screening or risk‐based protocols with each other or with controls.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Collection and Analysis</h3><p>Risk ratios (RR) and 95% confidence intervals (CI) were determined using Mantel‐Haenszel analyses with random effects.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Main Results</h3><p>17 eligible studies were included. In this meta‐analysis , screening was associated with a reduced risk against EOGBS disease compared either with risk‐based protocols (10 studies, RR 0.43, 95% CI 0.32–0.56), or with no policy (4 studies, RR 0.31 95% CI 0.11‐0.84). Meta‐analysis could not demonstrate a significant effect of risk‐based protocols vs. no policy (7 studies, RR 0.86, 95% CI 0.61‐1.20). In studies reporting on the use of antibiotics, screening was not associated with higher antibiotic administration rates (31% vs 29%).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Screening‐based protocols were associated with lower incidences of EOGBS disease compared to risk‐based protocols, while not clearly overexposing women to antibiotics. This information is of relevance for future policymaking.</p></section>
What problem does this paper attempt to address?